Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Access to medicines and treatment news

Show

From To
Preventing and treating HIV in Saint Petersburg

According to the Centre for AIDS Prevention and Control in Saint Petersburg in the Russian Federation, fewer people are becoming infected with HIV in the city. “Ten years ago, Saint Petersburg was among the top five most affected cities in the Russian Federation. Now it is only the 14th most affected,” said Denis Gusev, Head Physician of the AIDS centre.

Published
21 February 2018
From
UNAIDS
Mylan (MYL) Announces Tentative Approval for Combination HIV Treatment DTG/FTC/TAF Under FDA's PEPFAR Program

Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced receipt of tentative approval from the U.S. Food and Drug Administration (FDA) under the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) for its New Drug Application for Dolutegravir, Emtricitabine, and Tenofovir Alafenamide Tablets, 50 mg/200 mg/25 mg. The antiretroviral (ARV) will be immediately available in developing countries as a first-line regimen for people being treated for HIV/AIDS.

Published
20 February 2018
From
Mylan press release
Michel Kazatchkine: Winds of hope on HIV/AIDS in Eastern Europe and Central Asia?

Much of the media coverage focused on the intransigence of the government of the Russian Federation to changing its prevention policies around HIV/AIDS. However, this focus also obscures the fact that in Eastern Europe and Central Asia which has been much maligned over the past decade for its slowness in responding to the HIV/AIDS epidemic, we are now beginning to see strong hints that public health initiatives based on scientific evidence are taking on a legitimacy across the region.

Published
20 February 2018
From
BMJ
VICTORY: Publix Reverses Stance. Will Make PrEP Available To Employees

Today, after a week-long battle, Publix announced they reversed their stance on providing PrEP (pre-exposure prophylaxis) to prevent the transmission of HIV to their more than 188,000 employees across 7 southern states.

Published
07 February 2018
From
Equality Florida
He can't get proper HIV treatment in Venezuela. But he's being deported anyway

Ricardo Querales, who is HIV positive, faces deportation back to Venezuela, where he claims he will die because there is no medication to treat his illness.

Published
05 February 2018
From
Miami Herald
Study finds more than half of patients worldwide don’t access HIV treatment until immune systems are severely compromised

Data from nearly a million patients starting treatment for HIV across the world over the last decade shows 55 percent of them accessed antiretroviral treatment only after their immune cell — or CD4 — counts had dropped below 200, leaving them extremely vulnerable to illnesses and infections.

Published
02 February 2018
From
Science Speaks
HIV Medicine Association chair argues new HHS division ‘defies fundamental medical ethic’

“The new HHS division, like other ‘religious freedom’ efforts across the country, is a thinly disguised invitation to stigmatize and discriminate against LGBTQ individuals in the name of religion,” said HIV Medicine Association Chair Melanie Thompson.

Published
30 January 2018
From
Healio
China Introduces Low-Cost, Single-Pill HIV Treatment

Five months after receiving approval from the China Food and Drug Administration, British pharmaceutical giant GlaxoSmithKline (GSK) on Saturday introduced its market-leading antiretroviral drug Triumeq, which contains three active ingredients in a single pill.

Published
24 January 2018
From
Sixth Tone
American HIV Activists Prepare for What Lies Ahead in 2018

In the past year, health advocacy in the U.S. was a real stressor. President Donald Trump (along with the GOP-led houses of Congress) came into office fully focused on dismantling the Affordable Care Act (ACA) and reforming taxes to benefit the wealthy. This move could have taken us back to the days of AIDS Drug Assistance Program (ADAP) waiting lists, people with HIV being denied coverage, and people being refused coverage for pre-exposure prophylaxis (PrEP).

Published
16 January 2018
From
The Body
India to launch national program to control viral hepatitis and aims to negotiate lower drug prices

The health ministry is set to roll out a National Program for the Control of Viral Hepatitis from the 2018-19 financial year. An antiviral treatment that costs anywhere between $63,000 and $94,000 for the full course in the USA and Europe is to be provided free of cost at all government health organizations.

Published
09 January 2018
From
Pharma Letter
← First12345...129Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.